Latest news
AI can flag hidden cardiac risk. The dangerous part is what health systems do next
A new peer-reviewed review maps the growing use of artificial intelligence across ECG interpretation, cardiovascular imaging, arrhythmia detection, heart failure prediction and wearable monitoring. The technology is advancing rapidly. Evidence standards, accountability, reimbursement and care pathways are not.
ASCO 2026: GI cancers are finally moving out of oncology’s blind spot
ASCO 2026: AI is entering cancer care before the rules are ready
ASCO 2026: Are we overtreating cancer?
ASCO 2026: Why oncology is also paying attention to GLP-1 medicines
Regulators Start Writing the Rules for AI-Driven Medicines
AI Pathology Moves From Demo to Workflow
FDA Puts AI Inside the Evidence Machine
AlphaGenome Makes Variant Interpretation Political
AI Diagnosis Has Entered the Access Debate
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.